Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib PK/PD in HCC with Child-Pugh B Cirrhosis
NCT04051853Phase 2Terminated
- Sponsor
- University of Amsterdam
- Start
- May 2014
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in hepatocellular carcinoma (HCC), sponsored by University of Amsterdam. Started May 2014; status: terminated.
02
Drugs
sorafenib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT04051853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04051853.